669 related articles for article (PubMed ID: 28915103)
21. Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease.
Wang JH; Ou HY; Yen YH; Hung CH; Lu SN
Liver Int; 2023 Sep; 43(9):1901-1908. PubMed ID: 37249034
[TBL] [Abstract][Full Text] [Related]
22. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
[TBL] [Abstract][Full Text] [Related]
24. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.
Yokoo T; Serai SD; Pirasteh A; Bashir MR; Hamilton G; Hernando D; Hu HH; Hetterich H; Kühn JP; Kukuk GM; Loomba R; Middleton MS; Obuchowski NA; Song JS; Tang A; Wu X; Reeder SB; Sirlin CB;
Radiology; 2018 Feb; 286(2):486-498. PubMed ID: 28892458
[TBL] [Abstract][Full Text] [Related]
25. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis.
Chen J; Allen AM; Therneau TM; Chen J; Li J; Hoodeshenas S; Chen J; Lu X; Zhu Z; Venkatesh SK; Song B; Ehman RL; Yin M
Eur Radiol; 2022 Feb; 32(2):950-958. PubMed ID: 34432123
[TBL] [Abstract][Full Text] [Related]
26. Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting.
Ahn SB; Jun DW; Kang BK; Kim M; Chang M; Nam E
Medicine (Baltimore); 2018 Dec; 97(50):e13636. PubMed ID: 30558054
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
Lee HA; Kim SS; Choi JY; Seo YS; Park BJ; Sim KC; Kim SU
Abdom Radiol (NY); 2022 Nov; 47(11):3733-3745. PubMed ID: 35962809
[TBL] [Abstract][Full Text] [Related]
28. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
[TBL] [Abstract][Full Text] [Related]
29. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
de Lédinghen V; Wong GL; Vergniol J; Chan HL; Hiriart JB; Chan AW; Chermak F; Choi PC; Foucher J; Chan CK; Merrouche W; Chim AM; Le Bail B; Wong VW
J Gastroenterol Hepatol; 2016 Apr; 31(4):848-55. PubMed ID: 26514665
[TBL] [Abstract][Full Text] [Related]
30. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
31. A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.
Bao J; Lv Y; Wang K; Wang Q; Chen Y; Dong Y; Zhu Y; Wang W
J Ultrasound Med; 2023 Jul; 42(7):1481-1489. PubMed ID: 36583414
[TBL] [Abstract][Full Text] [Related]
32. iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
Hirooka M; Ogawa S; Koizumi Y; Yoshida Y; Goto T; Yasuda S; Yamahira M; Tamai T; Kuromatsu R; Matsuzaki T; Suehiro T; Kamada Y; Sumida Y; Hiasa Y; Toyoda H; Kumada T
J Gastroenterol; 2024 Jun; 59(6):504-514. PubMed ID: 38553657
[TBL] [Abstract][Full Text] [Related]
33. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
[TBL] [Abstract][Full Text] [Related]
34. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.
Shen F; Zheng RD; Mi YQ; Wang XY; Pan Q; Chen GY; Cao HX; Chen ML; Xu L; Chen JN; Cao Y; Zhang RN; Xu LM; Fan JG
World J Gastroenterol; 2014 Apr; 20(16):4702-11. PubMed ID: 24782622
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study.
Yazdani L; Rafati I; Gesnik M; Nicolet F; Chayer B; Gilbert G; Volniansky A; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Tang A; Cloutier G
Ultrasound Med Biol; 2023 Oct; 49(10):2264-2272. PubMed ID: 37482477
[TBL] [Abstract][Full Text] [Related]
36. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
[TBL] [Abstract][Full Text] [Related]
38. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.
Baumeler S; Jochum W; Neuweiler J; Bergamin I; Semela D
Swiss Med Wkly; 2019 Apr; 149():w20077. PubMed ID: 31026041
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
Runge JH; van Giessen J; Draijer LG; Deurloo EE; Smets AMJB; Benninga MA; Koot BGP; Stoker J
Eur Radiol; 2021 Mar; 31(3):1588-1596. PubMed ID: 32910234
[TBL] [Abstract][Full Text] [Related]
40. Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard.
Ajmera VH; Cachay ER; Ramers CB; Bassirian S; Singh S; Bettencourt R; Richards L; Hamilton G; Middleton M; Fowler K; Sirlin C; Loomba R
Clin Infect Dis; 2021 Jun; 72(12):2124-2131. PubMed ID: 32975278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
